# LA Improves the Prognosis of Patients With ICVD After Surgery

> **NCT05656209** · NA · NOT_YET_RECRUITING · sponsor: **Huaqiu Zhang** · enrollment: 236 (estimated)

## Conditions studied

- Ischemia; Cerebrovascular
- Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus acidophilus

## Key facts

- **NCT ID:** NCT05656209
- **Lead sponsor:** Huaqiu Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-12-18
- **Primary completion:** 2022-12-18
- **Final completion:** 2027-12-31
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656209, "LA Improves the Prognosis of Patients With ICVD After Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05656209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*